Abstract
In patients with head and neck cancers (HNC) flourine-18 (F18) fluorodeoxyglucose (FDG) positron emission tomography/magnetic resonance imaging (PET/MRI) imaging shows a similar performance to PET/computed tomography (CT) in terms of image and fusion quality, lesion prominence, anatomic localization, and number of detected lesions. Although studies investigating the accuracy of PET/MRI in tumor and node staging give conflicting results, there is a prediction that it may provide a better evaluation of locoregional spread compared to PET/CT. However, since most studies include small patient groups, studies with larger patient groups are needed to definitively determine the clinical role of PET/MRI imaging. FDG PET/MRI imaging combined with diffusion-weighted imaging provides excellent results for detecting residual/recurrent disease after radiotherapy. PET/MRI has excellent and similar diagnostic performance to PET/CT in detecting distant metastases and distant second primary cancer in HNC patients.
Keywords: Head and neck cancers, FDG PET imaging, PET/MR imaging
References
Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6:92.
Chow LQM. Head and neck cancer. N Engl J Med. 2020;382:60-72.
Murphy BA, Wulff-Burchfield E, Ghiam M, Bond SM, Deng J. Chronic systemic symptoms in head and neck cancer patients. J Natl Cancer Inst Monogr. 2019;2019:lgz004.
Pisani P, Airoldi M, Allais A, et al. Metastatic disease in head & neck oncology. Acta Otorhinolaryngol Ital. 2020;40:S1-S86.
Becker M, Monnier Y, de Vito C. MR imaging of laryngeal and hypopharyngeal cancer. Magn Reson Imaging Clin N Am. 2022;30:53-72.
Ng SP, Pollard C 3rd, Berends J, et al. Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy. Cancer. 2019;125:1823-1829.
Queiroz MA, Huellner MW. PET/MR in cancers of the head and neck. Semin Nucl Med. 2015;45:248-265.
Galgano SJ, Marshall RV, Middlebrooks EH, McConathy JE, Bhambhvani P. PET/MR imaging in head and neck cancer: current applications and future directions. Magn Reson Imaging Clin N Am. 2018;26:167-178.
Mukherjee S, Fischbein NJ, Baugnon KL, Policeni BA, Raghavan P. Contemporary ımaging and reporting strategies for head and neck cancer: MRI, FDG PET/MRI, NI-RADS, and carcinoma of unknown primary-AJR expert panel narrative review. AJR Am J Roentgenol. 2023;220:160-172.
Varoquaux A, Rager O, Poncet A, et al. Detection and quantification of focal uptake in head and neck tumours: (18)F-FDG PET/MR versus PET/CT. Eur J Nucl Med Mol Imaging. 2014;41:462-475.
Drzezga A, Souvatzoglou M, Eiber M, et al. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses. J Nucl Med. 2012;53:845-855.
Wiesmu ¨ller M, Quick HH, Navalpakkam B, et al. Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT. Eur J Nucl Med Mol Imaging. 2013;40:12-21.
Bini J, Izquierdo-Garcia D, Mateo J, et al. Preclinical evaluation of MR attenuation correction versus CT attenuation correction on a sequential whole-body MR/PET scanner. Invest Radiol. 2013;48:313-322.
Arabi H, Rager O, Alem A, Varoquaux A, Becker M, Zaidi H. Clinical assessment of MR-guided 3-class and 4-class attenuation correction in PET/MR. Mol Imaging Biol. 2015;17:264-276.
Varoquaux A, Rager O, Lovblad KO, et al. Functional imaging of head and neck squamous cell carcinoma with diffusion-weighted MRI and FDG PET/CT: quantitative analysis of ADC and SUV. Eur J Nucl Med Mol Imaging. 2013 Jun;40:842–852.
Freihat O, Zolta ´n T, Pinter T, et al. Correlation be tween tissue cellularity and metabolism repre sented by diffusion-weighted imaging (DWI) and 18F-FDG PET/MRI in head and neck cancer (HNC). Cancers. 2022;14:847.
Fruehwald-Pallamar J, Czerny C, Mayerhoefer ME, et al. Functional imaging in head and neck squa mous cell carcinoma: Correlation of PET/CT and diffusion-weighted imaging at 3 Tesla. Eur J Pediatr. 2011;38:1009–1019.
Min M, Lee MT, Lin P, et al. Assessment of serial multi-parametric functional MRI (diffusion-weighted imaging and R2*) with18F-FDG-PET in patients with head and neck cancer treated with radiation therapy. Br J Radiol. 2016;89:20150530.
Rasmussen JH, Nørgaard M, Hansen AE, et al. Feasibility of multiparametric imaging with PET/ MR in head and neck squamous cell carcinoma. J Nucl Med. 2017;58:69–74.
Covello M, Cavaliere C, Aiello M, et al. Simulta neous PET/MR head–neck cancer imaging: Prelim inary clinical experience and multiparametric evaluation. Eur J Radiol. 2015;84:1269–1276.
Cheng Y, Bai L, Shang J, et al. Preliminary clinical results for PET/MR compared with PET/CT in patients with nasopharyngeal carcinoma. Oncol Rep. 2020;43:177–187.
Schaarschmidt BM, Heusch P, Buchbender C, et al. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a com parison between MRI, PET/CT and integrated PET/MRI. Eur J Nucl Med Mol Imaging. 2016;43:92–102.
Huang C, Song T, Mukherji SK, et al. Comparative study between ıntegrated positron emission to mography/magnetic resonance and positron emission tomography/computed tomography in the T and N staging of hypopharyngeal cancer: an ınitial result. J Comput Assist Tomogr. 2020;44:540–545.
Sekine T a, de Galiza Barbosa F, Kuhn FP, et al. PET1MR versus PET/CT in the initial staging of head and neck cancer, using a trimodality PET/ CT1MR system. Clin Imaging. 2017;42:232–239.
Chan SC, Yeh CH, Yen TC, et al. Clinical utility of simultaneous whole-body 18F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2018;45:1297–1308.
Kuhn FP, Hu ¨llner M, Mader CE, et al. Contrast enhanced PET/MR imaging versus contrast enhanced PET/CT in head and neck cancer: how much MR information is needed? J Nucl Med. 2014;55:551–558.
Meerwein CM, Pizzuto DA, Vital D, et al. Use of MRI and FDG-PET/CT to predict fixation of advanced hypopharyngeal squamous cell carcinoma to pre vertebral space. Head Neck. 2019;41:503–510.
Sekine T b, Barbosa FG, Delso G, et al. Local resectability assessment of head and neck cancer: Positron emission tomography/MRI versus positron emission tomography/CT. Head Neck. 2017;39:1550–1558.
Medvedev O, Hedesiu M, Ciurea A, et al. Perineu ral spread in head and neck malignancies: imaging findings- an updated literature review. Bosn J Basic Med Sci. 2022;22:22–38.
Lee H, Lazor JW, Assadsangabi R, et al. An ım ager’s guide to perineural tumor spread in head and neck cancers: radiologic footprints on 18F FDG PET, with CT and MRI correlates. J Nucl Med. 2019;60:304–311.
Abdelaziz TT, Abdel Razek AAK. Magnetic resonance imaging of perineural spread of head and neck cancer. Magn Reson Imaging Clin N Am. 2022;30:95–108.
CaoC, XuY, HuangS, et al.Locoregional extension patterns of nasopharyngeal carcinoma detected by FDGPET/MR.Front Oncol. 2021;11:763114.
Audet N, BeasleyNJ, MacMillan C, et al. Lymphatic vessel density, nodal metastases, and prognosis in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2005;131:1065–1070.
Becker M, de Vito C, Dulguerov N, Zaidi H. PET/MR ımaging in head and neck cancer. Magn Reson Imaging Clin N Am. 2023;31:539-564.
Platzek I, Beuthien-Baumann B, Schneider M, et al. FDG PET/MR for lymph node staging in head and neck cancer. Eur J Radiol. 2014;83:1163-1168.
Cebeci S, Aydos U, Yeniceri A, et al. Diagnostic performance of FDG PET/MRI for cervical lymph node metastasis in patients with clinically N0 head and neck cancer. Eur Rev Med Pharmacol Sci. 2023;27:4528–4535.
Crimı` F, Borsetto D, Stramare R, et al. [18F]FDG PET/MRI versus contrast-enhanced MRI in detecting regional HNSCC metastases. Ann Nucl Med. 2021;35:260–269.
Mundada P, Varoquaux AD, Lenoir V, et al. Utility of MRI with morphologic and diffusion weighted imaging in the detection of post-treatment nodal disease in head and neck squamous cell carcinoma. Eur J Radiol. 2018;101:162–169.
Vandecaveye V, De Keyzer F, Vander Poorten V, et al. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology. 2009;251:134–146.
de Bondt RB, Hoeberigs MC, Nelemans PJ, et al. Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma. Neuroradiology. 2009;51:183–192.
Dirix P, Vandecaveye V, De Keyzer F, et al. Diffu sion-weighted MRI for nodal staging of head and neck squamous cell carcinoma: impact on radio therapy planning. Int J Radiat Oncol Biol Phys. 2010;76:761–766.
Driessen JP, van Kempen PM, van der Heijden GJ, et al. Diffusion-weighted imaging in head and neck squamous cell carcinomas: a systematic review. Head Neck. 2015;37:440–448.
Katirtzidou E, Rager O, Varoquaux AD, et al. Detec tion of distant metastases and distant second pri mary cancers in head and neck squamous cell carcinoma: comparison of [18F]FDG PET/MRI and [18F]FDG PET/CT. Insights Imaging. 2022;13:121-143.
Gao S, Li S, Yang X, Tang Q. 18FDG PET-CT for distant metastases in patients with recurrent head and neck cancer after definitive treatment. A meta-analysis. Oral Oncol. 2014;50:163-167.
Yeh CH, Chan SC, Lin CY, et al. Comparison of 18F-FDG PET/MRI, MRI, and 18F-FDG PET/CT for the detection of synchronous cancers and distant metastases in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 2020;47:94-104.
de Bree R, Senft A, Coca-Pelaz A, et al. Detection of Distant Metastases in Head and Neck Cancer: Changing Landscape. Adv Ther. 2018;35:161-172.
Chandarana H, Heacock L, Rakheja R, et al. Pulmonary nodules in patients with primary malignancy: comparison of hybrid PET/MR and PET/CT imaging. Radiology. 2013;268:874-881.
Lee KH, Park CM, Lee SM, et al. Pulmonary nodule detection in patients with a primary malignancy using hybrid PET/MRI: is there value in adding contrast-enhanced MR imaging? PLoS One. 2015;10:e0129660.
Schwenzer NF, Schraml C, Mu¨ller M, et al. Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging--pilot study. Radiology. 2012;264:551-558.
vanWeertS, HendrickxJJ, LeemansCR. Carcinoma of unknown primary: diagnostics and the potential of transoral surgery. In: Vermorken JB, Budach V, Leemans CR, et al, editors. Critical issues in head and neck oncology. Cham: Springer; 2023.
Brierley JD, Gospodarowicz MK, Wittekind C, et al. editors. UICC TNM classification of malignant tumours. 8th edition. Hoboken, New Jersey: Wiley Blackwell: Union for International Cancer Control; 2017.
Kalavacherla S, Sanghvi P, Lin GY, Guo T. Updates in the management of unknown primary of the head and neck. Front Oncol. 2022;12:991838.
Chen B, Zhang H, Liu D, Wang X, Ji B, Gao S. Diagnostic performance of 18F-FDG PET/CT for the detection of occult primary tumors in squamous cell carcinoma of unknown primary in the head and neck: a single-center retrospective study. Nucl Med Commun. 2021;42:523-527.
Rudmik L, Lau HY, Matthews TW, et al. Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: a prospective clinical trial. Head Neck. 2011;33:935-940.
Ruhlmann V, Ruhlmann M, Bellendorf A, et al. Hybrid imaging for detection of carcinoma of un known primary: a preliminary comparison trial of whole-body PET/MRI versus PET/CT. Eur J Radiol. 2016;85:1941-1947.
Noij DP, Martens RM, Zwezerijnen B, et al. Diagnostic value of diffusion-weighted imaging and 18F-FDG-PET/CT for the detection of unknown pri mary head and neck cancer in patients presenting with cervical metastasis. Eur J Radiol. 2018;107:20-25.
Sheikhbahaei S, Taghipour M, Ahmad R, et al. Diagnostic Accuracy of Follow-Up FDG PET or PET/CT in Patients With Head and Neck Cancer Af ter Definitive Treatment: A Systematic Review and Meta-Analysis. AJR Am J Roentgenol. 2015;205:629-639.
Cheung PK, Chin RY, Eslick GD. Detecting residual/recurrent head neck squamous cell carcinomas using PET or PET/CT: systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2016;154:421-432.
Gupta T, Master Z, Kannan S, et al. Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2011;38:2083-2095.
Abdel Razek AA, Kandeel AY, Soliman N, et al. Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol. 2007;28:1146-1152.
Vandecaveye V, De Keyzer F, Nuyts S, et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radio therapy: correlation between radiologic and histo pathologic findings. Int J Radiat Oncol Biol Phys. 2007;67:960-971.
Ailianou A, Mundada P, De Perrot T, et al. MRI with DWI for the detection of posttreatment head and neck squamous cell carcinoma: why morphologic MRI criteria matter. AJNR Am J Neuroradiol. 2018;39:748-755.
Lenoir V, Delattre BMA, M’RaD Y, et al. Diffusion weighted imaging to assess HPV-positive versus HPV-negative oropharyngeal squamous cell carcinoma: the importance of b-values. AJNR Am J Neuroradiol. 2022;43:905-912.
de Perrot T, Lenoir V, Domingo Ayllo ´nM, et al. Apparent diffusion coefficient histograms of human papillomavirus-positive and human papillomavirus negative head and neck squamous cell carcinoma: assessment of tumor heterogeneity and comparison with histopathology. AJNR Am J Neuroradiol. 2017;38:2153-260.
Becker M, Varoquaux AD, Combescure C, et al. Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences. Eur Radiol. 2018;28:651–663.
King AD, Keung CK, Yu KH, et al. T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma. AJNR Am J Neuroradiol. 2013;34:1237-1241.
Ashour MM, Darwish EAF, Fahiem RM, Abdelaziz TT. MRI posttreatment surveillance for head and neck squamous cell carcinoma: proposed MR NI-RADS criteria. AJNR Am J Neuroradiol. 2021;42:1123-1129.
Patel LD, Bridgham K, Ciriello J, et al. PET/MR imaging in evaluating treatment failure of head and neck malignancies: a neck ımaging reporting and data system-based study. AJNR Am J Neuroradiol. 2022;43:435-441.
Martens RM, Noij DP, Koopman T, et al. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy. Eur J Radiol. 2019;113:39-50.
Pace L, Nicolai E, Cavaliere C, et al. Prognostic value of 18F-FDG PET/MRI in patients with advanced oropharyngeal and hypopharyngeal squamous cell carcinoma. Ann Nucl Med. 2021;35:479-484.
Chan SC, Yeh CH, Chang JT, Chang KP, Wang JH, Ng SH. Combing MRI perfusion and 18F-FDG PET/CT metabolic biomarkers helps predict survival in advanced nasopharyngeal carcinoma: a prospective multimodal ımaging study. Cancers (Basel). 2021;13:1550.
Connor S, Sit C, Anjari M, et al. The ability of post-chemoradiotherapy DWI ADCmean and 18F-FDG SUVmax to predict treatment outcomes in head and neck cancer: impact of human papilloma virus oropharyngeal cancer status. J Cancer Res Clin Oncol. 2021;147:2323-2336.
